Buy Retatrutide – Research Peptide | PEPTEX

Lipidated 36-residue synthetic peptide. CAS 2381089-83-2. Purity ≥98% by HPLC and MS. Contains a C20 fatty diacid chain conferring albumin-binding properties and prolonged half-life. Slight yellow tint in solution is normal. Reconstitute in sterile aqueous solution. Supplied in a sealed borosilicate glass vial. Intended for laboratory and research use only. Store at −20°C; protect from light and moisture.

Price: EUR | Brand: PEPTEX | In Stock | EU-wide delivery, up to 7 business days

Rating: 5/5 (433 reviews)

Customer Reviews

Elena S. — ★★★★★
Packaging is always immaculate. Cold chain maintained perfectly on all four orders. The retat itself works as the published research suggests. Consistent quality.

simone_it — ★★★★★
The triple agonist mechanism is noticeable compared to tirzepatide. I ran both (tirz for 4 months, then switched to retat). The energy expenditure component is real — I'm warmer, more energetic, and the fat loss pace picked up even though I'm already lean

Filippo — ★★★★★
Initially skeptical about the Phase II hype. Ordered a small amount to test. Results were convincing enough that I've now ordered three times. Peptex support answered my dosing questions within hours.

Bram87 — ★★★★
Decent product. Took about three weeks longer than tirzepatide to really feel the appetite suppression, but once it kicked in the effect was stronger. The GI adjustment period was similar. Would rate 5 if the titration phase wasn't so slow.

Oskar88 — ★★★★★
Partner and I run retatrutide together. Both on our second cycle. He's more focused on the metabolic effects, I'm interested in the liver fat data. Both very happy with the quality and consistency from peptex.

Available Sizes

• 10mg — 134 EUR
• 30mg — 204 EUR
• 60mg — 349 EUR

Storage Recommendations

Research References

1. Triple-Hormone-Receptor Agonist Reta (RTT) for Obesity — NEJM / PubMed (2023)
2. Reta (RTT) in type 2 diabetes — Phase 2 — Lancet / PubMed (2023)